SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Details Narrative) - USD ($)											12 Months Ended
	Jul. 26, 2022	Jul. 26, 2022	Jul. 22, 2022	Jul. 14, 2022	May 03, 2022	Feb. 15, 2022	Feb. 11, 2022	Sep. 16, 2021	Feb. 11, 2021	Jan. 14, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 30, 2021	Feb. 14, 2022	Dec. 30, 2020
Class of Stock [Line Items]
Common stock voting rights											The holders of the Company’s common stock are entitled to one vote per share.
Common stock, shares authorized											100,000,000	100,000,000
Preferred Stock, shares authorized											20,000,000	20,000,000			20,000,000
Proceeds from common stock											$ 17,222,099	$ 21,614,488
Number of shares issued												4,434
Exercise price												$ 233.00
Cashless exercise of stock option												2,876
Inducement expense												$ 1,125,291
Incentive plan description					(i) increase the aggregate number of shares available for the grant of awards by 146,083 shares to a total of 200,000 shares, and (ii) add an “evergreen” provision whereby the number of shares authorized for issuance pursuant to awards under the Incentive Plan will be automatically increased on the first trading date immediately following the date the Company issues any share of Common Stock (defined below) to any person or entity, to the extent necessary so that the number of shares of the Company’s Common Stock authorized for issuance under the Incentive Plan will equal the greater of (x) 200,000 shares, and (y) 15% of the total number of shares of the Company’s Common Stock outstanding as of such issuance date. The Plan Amendment was approved by the Company’s stockholders at a special meeting of the Company’s stockholders held on July 14, 2022.
Stock option Exercised											0	2,876
Cashless issuance of common stock											0	2,685
Stock based compensation, expenses											$ 2,416,266	$ 12,304,514
Options to purchase, shares											25,500	2,482
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right												4,434
Class of warrant exercised												2,188
Exchange of common stock warrants												2,188
Purchase of warrant outstanding												19,464
Purchase of common stock												13,176
Inducement expenses related to fair value of new award												$ 826,577
Ameri [Member]
Class of Stock [Line Items]
Purchase of common stock												4,434
Magic Med Industries [Member]
Class of Stock [Line Items]
Number of shares issued								199,025
Number of values issued								$ 39,042,282
Common Stock [Member]
Class of Stock [Line Items]
Purchase of common stock							60,000
Exercise of warrants, shares												52,861
Number of shares issued							400,000					65,509
Conversion of stock options into restricted stock, shares											1,223
Cashless exercise of stock option												2,685
Conversion of warrants												65,509
Restricted Stock units outstanding											899
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right							27.50
Common Stock [Member] | Maximum [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right							60,000
Warrant [Member]
Class of Stock [Line Items]
Purchase of common stock												55,861
Proceeds from issuance of warrants												$ 3,285,171
Cashless exercise of stock option												2,685
Conversion of warrants												20,307
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right							400,000
Sale of stock price per share							$ 25.00
Purchase of additional warrants														60,000
Exchange of common stock warrants												13,176
Placement Agent Preferred Investment Options [Member]
Class of Stock [Line Items]
Purchase of common stock		70,000
Exercise price	$ 10.00	$ 10.00
Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Conversion of stock options into restricted stock, shares											1,223
Stock based compensation, expenses											$ 2,416,266	$ 12,304,514
Stock-based compensation, unamortized											$ 3,225,701
Weighted average period											2 years 9 months 18 days
Common stock , shares issued restricted stock awards											8,633	55,717
Restricted Stock Units (RSUs) [Member] | Long Term Incentive Plan [Member]
Class of Stock [Line Items]
Number of shares vested											64,053	62,013
Restricted Stock Units (RSUs) [Member] | Common Stock [Member]
Class of Stock [Line Items]
Common stock , shares issued restricted stock awards											1,856
Number of shares vested											62,492
Restricted Stock [Member]
Class of Stock [Line Items]
Conversion of stock options into restricted stock, shares											899
Inducement expense												$ 298,714
Stock based compensation, expenses											$ 24,363	$ 231,631
Options to purchase, shares												6,509	843
Common stock , shares issued restricted stock awards											331	1,485
Restricted Stock [Member] | Long Term Incentive Plan [Member]
Class of Stock [Line Items]
Number of shares vested											62,492	55,717
Restricted Stock units outstanding											126,545	117,730
Restricted Stock [Member] | Common Stock [Member]
Class of Stock [Line Items]
Common stock , shares issued restricted stock awards											708
Share-Based Payment Arrangement, Option [Member]
Class of Stock [Line Items]
Stock based compensation, expenses											$ 180,042	$ 60,856
Stock-based compensation, unamortized											$ 240,850
Options to purchase, shares												11,209
Equity Option [Member]
Class of Stock [Line Items]
Weighted average period											1 year 10 months 24 days
Registered Direct Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Purchase of common stock			375,000								375,000
Purchase of common stock			258,500
Proceeds from issuance of warrants			$ 3,000,000
Number of shares issued			116,500
Exercise price			$ 0.0001
Exercise price											$ 7.78
PIPE Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Purchase of common stock			625,000								625,000
Purchase of common stock			509,000
Proceeds from issuance of warrants			$ 5,000,000
Number of shares issued			116,000
Exercise price											$ 7.78
Wainwright Amendment Agreements [Member]
Class of Stock [Line Items]
Purchase of common stock			122,000
Exercise price			$ 7.78			$ 27.50
Warrant expiration			Feb. 15, 2027
Underwriters [Member]
Class of Stock [Line Items]
Purchase of common stock						60,000
Purchase of common stock						60,000
Exercise of warrants, shares						60,000
Proceeds from issuance of warrants						$ 9,100,000
Offering expense						5,800,000
Warrant liability						3,600,000
Remaining recorded expenses						$ 300,000
Consultant [Member]
Class of Stock [Line Items]
Purchase of common stock												283
Value of shares issued, services												$ 33,467
Holder [Member] | Common Stock [Member]
Class of Stock [Line Items]
Number of shares issued												19,464
IPO [Member]
Class of Stock [Line Items]
Purchase of common stock						400,000
Purchase of common stock						400,000
Proceeds from common stock						$ 10,000,000
Offering [Member] | Expense [Member]
Class of Stock [Line Items]
Payments of stock issuance costs recorded expense									$ 527,000	$ 663,000
Offering [Member] | Common Stock [Member]
Class of Stock [Line Items]
Purchase of common stock									60,141	44,427
Proceeds from issuance of warrants									$ 12,800,000	$ 10,000,000
Exercise price										$ 225.00
Offering [Member] | Warrant [Member]
Class of Stock [Line Items]
Purchase of common stock									1,503,513	33,321
Share issued per share									$ 245.00	$ 247.50
Issuance of initial public offering									$ 11,624,401	$ 8,800,087
Amount allocated to share capital									7,016,401	4,617,087
Amount allocated to warrant liability									$ 5,135,000	$ 4,846,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, shares authorized											3,600,000	3,600,000			3,600,000
Preferred stock, conversion												3,275,407
Number of shares converted to common stock												65,509
Preferred stock outstanding											0	0
Number of shares issued												3,275,407
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock voting rights				Each share of Series C Preferred Stock was entitled to receive $0.10 in cash for each 10 whole shares of Series C Preferred Stock immediately prior to the Redemption. As of June 30, 2022, there were
Redeemable preferred stock, shares outstanding				52,684.548
Preferred Stock authorized for future issuances											100,000
PIPE Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Exercise price			$ 0.0001
RD Offering and Pipe Investment Options [Member]
Class of Stock [Line Items]
Proceeds from RD offerings	$ 8,000,000
Offerings costs	7,100,000		$ 251,357
Payments of allocated equity	3,200,000
Payments of investment option liability	4,300,000
Payments of stock issuance costs recorded expense	$ 400,000